Search

Your search keyword '"Ladon, Dariusz"' showing total 12 results

Search Constraints

Start Over You searched for: Author "Ladon, Dariusz" Remove constraint Author: "Ladon, Dariusz" Publication Year Range Last 3 years Remove constraint Publication Year Range: Last 3 years
12 results on '"Ladon, Dariusz"'

Search Results

1. TP53 mutation variant allele frequency of ≥10% is associated with poor prognosis in therapy-related myeloid neoplasms

2. A human fetal liver-derived infant MLL-AF4 acute lymphoblastic leukemia model reveals a distinct fetal gene expression program

3. Unraveling facets of MECOM-associated syndrome: somatic genetic rescue, clonal hematopoiesis, and phenotype expansion

4. TP53 mutation in therapy-related myeloid neoplasm defines a distinct molecular subtype

5. TP53 Mutation Status Defines a Distinct Clinicopathological Entity of Therapy-Related Myeloid Neoplasm, Characterized By Genomic Instability and Extremely Poor Outcome

6. Personalized Prediction Model to Risk Stratify Patients with Therapy-Related Myeloid Neoplasms

7. TP53 mutation in therapy-related myeloid neoplasm defines a distinct molecular subtype

8. TT52CAR19: Phase 1 Trial of CRISPR/Cas9 Edited Allogeneic CAR19 T Cells for Paediatric Relapsed/Refractory B-ALL

9. TP53mutation in therapy-related myeloid neoplasm defines a distinct molecular subtype

10. Comparison of World Health Organization and International Consensus Classification Guidelines for Myeloid Neoplasms Harboring TP53-Mutations Using an Independent International Cohort

11. TP53Mutation Status Defines a Distinct Clinicopathological Entity of Therapy-Related Myeloid Neoplasm, Characterized By Genomic Instability and Extremely Poor Outcome

12. Myeloid neoplasms arising after methotrexate therapy for autoimmune rheumatological diseases do not exhibit poor-risk molecular features.

Catalog

Books, media, physical & digital resources